ArticleJournal of thoracic disease2026
Diagnostic utility of pleural fluid adenosine deaminase in tuberculous pleural effusion in patients with exudative effusion: a retrospective multicenter study (ADATPE).
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculous pleural effusion (TPE) remains a diagnostic challenge, particularly in tuberculosis-endemic regions. Pleural fluid adenosine deaminase (pfADA) is widely used as a diagnostic biomarker; however, its optimal cutoff value may vary depending on the epidemiological context. This study aimed to optimise the diagnostic performance of pfADA by determining a new local cutoff, evaluating the conventional threshold (≥40 U/L), and assessing the diagnostic value of the pleural fluid lactate dehydrogenase (LDH)/ADA ratio. Methods: The ADATPE study was a retrospective, observational, multicenter analysis involving 276 patients with exudative pleural effusion from three tertiary Malaysian hospitals. Patients were categorized into definite, clinical, and non-TPE groups based on microbiological, histopathological, and clinical criteria. Receiver operating characteristic curve analysis and the Youden Index were used to identify an optimal local pfADA threshold. Results: PfADA demonstrated excellent diagnostic accuracy with an area under the receiver operating characteristic curve (AUC) of 0.852. A new local cutoff of ≥36 U/L improved sensitivity to 82.9% while maintaining specificity at 80.6%, outperforming the conventional threshold of ≥40 U/L. The combination of ADA ≥36 U/L and LDH/ADA ratio ≤16 yielded the highest diagnostic specificity (90.78%), positive predictive value (69.84%), and overall accuracy (83.70%). Conclusions: A revised pfADA cutoff of ≥36 U/L enhances diagnostic accuracy for TPE in Malaysian patients. PfADA remains a valuable diagnostic tool, but it should be interpreted in conjunction with other clinical and laboratory parameters. The LDH/ADA ratio is a valuable adjunct, particularly in cases that are borderline or inconclusive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.